Home > Products > Chemicals > Pharmaceutical Chemicals

Quick Details

• Type: Blood Testing Equipments
• Brand Name: Bioneovan
• Place of Origin: Beijing, China (Mainland)
• Model Number: Pathological analysis equipment
• samples: free
• Manufacture: Factory byself
• Specificity: > 98%
• Method: Colloidal golden Rapid test HIV
• Catagory: Blood group reagent HIV
• Use: dagnostic reagent HIV
• Specimen: human Serum or plasma HIV
• Accuracy: 99%+
• Payment term: FOB TT
• Certificate: GMP;ISO9001;ISO13485

Packaging & Delivery

HIV is the etiologic agent of Acquired Immune Deficiency Syndrome (AIDS). The virion is surrounded by a lipid envelope that is derived from host cell membrane. Several viral glycoproteins are on the envelope. Each virus contains two copies of positive-sense genomic RNAs. HIV-1 has been isolated from patients with AIDS and AIDS-related complex, and from healthy people with a high potential risk for developing AIDS. HIV-2 has been isolated from West African AIDS patients and from seropositive asymptomatic individuals. Both HIV-1 and -2 elicit an immune response. Detection of HIV antibodies in serum or plasma is the most efficient and common way to determine whether an individual has been exposed to HIV and to screen blood and blood products for HIV. Despite the differences in their biological characteristics, serological activities and genome sequences of HIV-1 and -2 show strong antigenic cross-reactivity. Most HIV-2 positive sera can be identified by using HIV-1 based serological tests.

The HIV-Card/Strip is a rapid test to qualitatively detect the presence of antibody to HIV-1 and/or -2 in serum or plasma specimen. The test utilizes a combination of protein A coated particles and multiple recombinant HIV proteins(including gp36, gp41, p24, gp120) to selectively detect antibody to the HIV-1 and HIV-2 in serum or plasma.

The HIV-Card/Strip is a qualitative, membrane based immunoassay for the detection of antibody to HIV in serum or plasma. The membrane is coated with recombinant HIV antigens on the test line region of the device. When a serum or plasma specimen is applied at one end of the membrane, it reacts with Protein A coated particle that has already been applied to the specimen pad at the same end. The mixture then migrates chromatographically towards the other end of the membrane and reacts with the recombinant HIV antigens on the membrane in the test line region. If the serum or plasma contains antibodies to HIV-1 or HIV-2, a colored line will appear in the test line region, showing a positive result. The absence of the colored line indicates that the serum or plasma does not contain the anti-HIV antibodies, showing a negative result. To serve as a procedural control, a colored line will always appear at the control line region if the test has been performed properly.